PTC Therapeutics Inc. buy Morgan Stanley
Start price
08.01.26
/
50%
€66.50
Target price
08.01.27
-
Performance (%)
-6.80%
Price
15.04.26
€61.18
Summary
This prediction is currently active. With a performance of -6.80%, the BUY prediction for PTC Therapeutics Inc. by Morgan_Stanley is down slightly. This prediction currently runs until 08.01.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | 1.124% | 1.124% |
| iShares Core DAX® | 0.444% | 3.030% |
| iShares Nasdaq 100 | 3.819% | 4.073% |
| iShares Nikkei 225® | 1.148% | 6.904% |
| iShares S&P 500 | 2.371% | 2.677% |
Comments by Morgan_Stanley for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Morgan_Stanley for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.60
20.08.25
20.08.25
€61.05
20.08.26
20.08.26
48.99%
15.04.26
15.04.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€48.60
07.03.25
07.03.25
€64.54
07.03.26
07.03.26
9.05%
08.03.26
08.03.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.80
13.12.24
13.12.24
€63.72
13.12.25
13.12.25
43.84%
14.12.25
14.12.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.80
19.12.23
19.12.23
€25.54
19.12.24
19.12.24
73.39%
20.12.24
20.12.24